221 related articles for article (PubMed ID: 37061460)
1. The Alzheimer's disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology.
Samuels JD; Moore KA; Ennerfelt HE; Johnson AM; Walsh AE; Price RJ; Lukens JR
Alzheimers Dement; 2023 Nov; 19(11):4908-4921. PubMed ID: 37061460
[TBL] [Abstract][Full Text] [Related]
2. Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease.
Castranio EL; Hasel P; Haure-Mirande JV; Ramirez Jimenez AV; Hamilton BW; Kim RD; Glabe CG; Wang M; Zhang B; Gandy S; Liddelow SA; Ehrlich ME
Alzheimers Dement; 2023 Jun; 19(6):2239-2252. PubMed ID: 36448627
[TBL] [Abstract][Full Text] [Related]
3. INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia.
Tsai AP; Lin PB; Dong C; Moutinho M; Casali BT; Liu Y; Lamb BT; Landreth GE; Oblak AL; Nho K
Neurobiol Dis; 2021 Jun; 153():105303. PubMed ID: 33631273
[TBL] [Abstract][Full Text] [Related]
4. INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease.
Lin PB; Tsai AP; Soni D; Lee-Gosselin A; Moutinho M; Puntambekar SS; Landreth GE; Lamb BT; Oblak AL
Alzheimers Dement; 2023 Jun; 19(6):2528-2537. PubMed ID: 36524682
[TBL] [Abstract][Full Text] [Related]
5. Pathological Roles of INPP5D in Alzheimer's Disease.
Chu YN; Akahori A; Takatori S; Tomita T
Adv Exp Med Biol; 2023; 1423():289-301. PubMed ID: 37525057
[TBL] [Abstract][Full Text] [Related]
6. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
7. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
[TBL] [Abstract][Full Text] [Related]
8. Microglia-specific ApoE knock-out does not alter Alzheimer's disease plaque pathogenesis or gene expression.
Henningfield CM; Arreola MA; Soni N; Spangenberg EE; Green KN
Glia; 2022 Feb; 70(2):287-302. PubMed ID: 34643971
[TBL] [Abstract][Full Text] [Related]
9. SHIP inhibition mediates select TREM2-induced microglial functions.
Ramakrishnan GS; Berry WL; Pacherille A; Kerr WG; Chisholm JD; Pedicone C; Humphrey MB
Mol Immunol; 2024 Jun; 170():35-45. PubMed ID: 38613944
[TBL] [Abstract][Full Text] [Related]
10. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
Baik SH; Kang S; Son SM; Mook-Jung I
Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
[TBL] [Abstract][Full Text] [Related]
11. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
[No Abstract] [Full Text] [Related]
12. CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer's disease.
Puntambekar SS; Moutinho M; Lin PB; Jadhav V; Tumbleson-Brink D; Balaji A; Benito MA; Xu G; Oblak A; Lasagna-Reeves CA; Landreth GE; Lamb BT
Mol Neurodegener; 2022 Jun; 17(1):47. PubMed ID: 35764973
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice.
Eskandari-Sedighi G; Crichton M; Zia S; Gomez-Cardona E; Cortez LM; Patel ZH; Takahashi-Yamashiro K; St Laurent CD; Sidhu G; Sarkar S; Aghanya V; Sim VL; Tan Q; Julien O; Plemel JR; Macauley MS
Mol Neurodegener; 2024 May; 19(1):42. PubMed ID: 38802940
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
Front Immunol; 2019; 10():2780. PubMed ID: 31849963
[TBL] [Abstract][Full Text] [Related]
15. CARD9 attenuates Aβ pathology and modifies microglial responses in an Alzheimer's disease mouse model.
Ennerfelt H; Holliday C; Shapiro DA; Zengeler KE; Bolte AC; Ulland TK; Lukens JR
Proc Natl Acad Sci U S A; 2023 Jun; 120(24):e2303760120. PubMed ID: 37276426
[TBL] [Abstract][Full Text] [Related]
16. The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's disease.
von Saucken VE; Jay TR; Landreth GE
Neurobiol Dis; 2020 Nov; 145():105072. PubMed ID: 32890775
[TBL] [Abstract][Full Text] [Related]
17. APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints.
Yin Z; Rosenzweig N; Kleemann KL; Zhang X; Brandão W; Margeta MA; Schroeder C; Sivanathan KN; Silveira S; Gauthier C; Mallah D; Pitts KM; Durao A; Herron S; Shorey H; Cheng Y; Barry JL; Krishnan RK; Wakelin S; Rhee J; Yung A; Aronchik M; Wang C; Jain N; Bao X; Gerrits E; Brouwer N; Deik A; Tenen DG; Ikezu T; Santander NG; McKinsey GL; Baufeld C; Sheppard D; Krasemann S; Nowarski R; Eggen BJL; Clish C; Tanzi RE; Madore C; Arnold TD; Holtzman DM; Butovsky O
Nat Immunol; 2023 Nov; 24(11):1839-1853. PubMed ID: 37749326
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer's disease.
Lee J; Kim DE; Griffin P; Sheehan PW; Kim DH; Musiek ES; Yoon SY
Aging Cell; 2020 Feb; 19(2):e13078. PubMed ID: 31800167
[TBL] [Abstract][Full Text] [Related]
19. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.
Bosch ME; Dodiya HB; Michalkiewicz J; Lee C; Shaik SM; Weigle IQ; Zhang C; Osborn J; Nambiar A; Patel P; Parhizkar S; Zhang X; Laury ML; Mondal P; Gomm A; Schipma MJ; Mallah D; Butovsky O; Chang EB; Tanzi RE; Gilbert JA; Holtzman DM; Sisodia SS
Mol Neurodegener; 2024 Feb; 19(1):18. PubMed ID: 38365827
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of transcriptome remodeling in plaque-associated and plaque-distant microglia during amyloid-β pathology progression in mice.
Hemonnot-Girard AL; Meersseman C; Pastore M; Garcia V; Linck N; Rey C; Chebbi A; Jeanneteau F; Ginsberg SD; Lachuer J; Reynes C; Rassendren F; Hirbec H
J Neuroinflammation; 2022 Sep; 19(1):234. PubMed ID: 36153535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
